Re: Momentum Players and Agoracom.com’s Rules
in response to
by
posted on
Dec 21, 2021 11:52AM
Toinv,your comment below,
"If Covid patients treated with apabetalone start walking out of the clinic in 2 days and if the heart and lung issues are addressed by apabetalone then look out Moderna here we come - to the Moon baby!"
If a tree in the forest falls and no one hears it,did it really fall??, assuming the covid trial results are initially showing good results where is the mass media war room /PR press room coming from?? It didn't help with the FDA BTD announcement which should have given the SP a huge bounce. Bad management and little financing help stalled any price appreciation with the BTD announcement. The SP with good covid results should give RVX SP the potential valuation of trading at 10 times the value it is now on the TSX. Not being on the Nasdaq makes it much harder to attact new investors and to get to that valuation. I am just hoping Eversana can solve all of RVX mismangements and get that proper valuation it deserves based on the science.